Figure 1From: Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapyOverall survival of HIV-seropositive patients with access to HAART (n = 10) (thin line) and T-/N-stage, age-matched HIV-seronegative patients (n = 10) (thick line) with anal cancer (p = NS).Back to article page